{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:17:31Z","timestamp":1791235051962,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,18]],"date-time":"2023-03-18T00:00:00Z","timestamp":1679097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,18]],"date-time":"2023-03-18T00:00:00Z","timestamp":1679097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s10815-023-02757-4","type":"journal-article","created":{"date-parts":[[2023,3,18]],"date-time":"2023-03-18T06:02:47Z","timestamp":1679119367000},"page":"1071-1081","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The HERA (Hyper-response Risk Assessment) Delphi consensus definition of hyper-responders for in-vitro fertilization"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9772-3613","authenticated-orcid":false,"given":"Ido","family":"Feferkorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Ata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. C.","family":"Esteves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"La Marca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Blockeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Conforti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. M.","family":"Fatemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Humaidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. T.","family":"Lainas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. W.","family":"Mol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Orvieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. P.","family":"Polyzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Santos-Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. K.","family":"Sunkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. L.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. M.","family":"Ubaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Urman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. G.","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Yarali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. H.","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,18]]},"reference":[{"key":"2757_CR1","unstructured":"Weiss MS, Luo C, Zhang Y, Chen Y, Kissin DM, Satten GA, et al. Fresh vs. frozen embryo transfer: new approach to minimize the limitations of using national surveillance data for clinical research. Fertil Steril [Internet]. Fertil Steril; 2022 [cited 2023 Feb 1]; Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca\/36567206\/."},{"key":"2757_CR2","doi-asserted-by":"crossref","unstructured":"Ata B. Haste makes waste: don\u2019t rush for a fresh embryo transfer in high responders. Human Reproduction [Internet]. Oxford Academic; 2020 [cited 2022 May 3];35:2660\u20132. Available from: https:\/\/academic.oup.com\/humrep\/article\/35\/12\/2660\/5917721.","DOI":"10.1093\/humrep\/deaa257"},{"key":"2757_CR3","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.fertnstert.2018.04.039","volume":"110","author":"NP Polyzos","year":"2018","unstructured":"Polyzos NP, Drakopoulos P, Parra J, Pellicer A, Santos-Ribeiro S, Tournaye H, et al. Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization\/intracytoplasmic sperm injection: a multicenter multinational analysis including \u223c15,000 women. Fertil Steril. 2018;110:661-670.e1 (Elsevier).","journal-title":"Fertil Steril"},{"key":"2757_CR4","doi-asserted-by":"crossref","unstructured":"Scaravelli G, Levi-Setti PE, Livi C, la Sala G, Ubaldi FM, Greco E, et al. Contribution of cryopreservation to the cumulative live birth rate: a large multicentric cycle-based data analysis from the Italian National Registry. J Assist Reprod Genet [Internet]. J Assist Reprod Genet; 2019 [cited 2022 Sep 6];36:2287\u201395. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31463873\/.","DOI":"10.1007\/s10815-019-01566-y"},{"key":"2757_CR5","doi-asserted-by":"crossref","unstructured":"Dahan MH, Tannus S, Seyhan A, Tan SL, Ata B. Combined modalities for the prevention of ovarian hyperstimulation syndrome following an excessive response to stimulation. Gynecol Endocrinol [Internet]. Gynecol Endocrinol; 2018 [cited 2022 Sep 6];34:252\u20135. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29057693\/.","DOI":"10.1080\/09513590.2017.1391206"},{"key":"2757_CR6","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.fertnstert.2016.08.048","volume":"106","author":"S Pfeifer","year":"2016","unstructured":"Committee of the American Society for Reproductive Medicine P, Pfeifer S, Butts MSCES, Dumesic D, Fossum G, Gracia MSCEC, et al. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril [Internet]. 2016;106:1634\u201347. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.08.048. ([cited 2022 May 1]).","journal-title":"Fertil Steril [Internet]"},{"key":"2757_CR7","first-page":"1","volume":"68","author":"C Tom\u00e1s","year":"2021","unstructured":"Tom\u00e1s C, Colmorn L, Rasmussen S, Lidegaard \u00d8, Pinborg A, Andersen AN. Annual incidence of severe ovarian hyperstimulation syndrome. Dan Med J Almindelige Danske Laegeforening. 2021;68:1\u20138.","journal-title":"Dan Med J Almindelige Danske Laegeforening"},{"key":"2757_CR8","doi-asserted-by":"crossref","unstructured":"Sood A, Goel A, Boda S, Mathur R. Prediction of significant OHSS by ovarian reserve and ovarian response - implications for elective freeze-all strategy. Hum Fertil (Camb) [Internet]. Hum Fertil (Camb); 2022 [cited 2023 Feb 2];25:390\u20136. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca\/32835544\/.","DOI":"10.1080\/14647273.2020.1809021"},{"key":"2757_CR9","doi-asserted-by":"crossref","unstructured":"The ESHRE Guideline Group on Ovarian Stimulation, Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, et al. ESHRE guideline: ovarian stimulation for IVF\/ICSI\u2020. Hum Reprod Open [Internet]. Oxford Academic; 2020 [cited 2022 Mar 17];2020:1\u201313. Available from: https:\/\/academic.oup.com\/hropen\/article\/2020\/2\/hoaa009\/5827574.","DOI":"10.1093\/hropen\/hoaa009"},{"key":"2757_CR10","doi-asserted-by":"crossref","unstructured":"Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod [Internet]. Hum Reprod; 2011 [cited 2022 Mar 17];26:1768\u201374. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca\/21558332\/.","DOI":"10.1093\/humrep\/der106"},{"key":"2757_CR11","doi-asserted-by":"crossref","unstructured":"Bosdou JK, Venetis CA, Tarlatzis BC, Grimbizis GF, Kolibianakis EM. Higher probability of live-birth in high, but not normal, responders after first frozen-embryo transfer in a freeze-only cycle strategy compared to fresh-embryo transfer: a meta-analysis. Human Reproduction [Internet]. Oxford Academic; 2019 [cited 2022 Mar 17];34:491\u2013505. Available from: https:\/\/academic.oup.com\/humrep\/article\/34\/3\/491\/5303709.","DOI":"10.1093\/humrep\/dey388"},{"key":"2757_CR12","doi-asserted-by":"crossref","unstructured":"Roque M, Haahr T, Geber S, Esteves SC, Humaidan P. Fresh versus elective frozen embryo transfer in IVF\/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes. Hum Reprod Update [Internet]. Oxford Academic; 2019 [cited 2022 Jun 25];25:2\u201314. Available from: https:\/\/academic.oup.com\/humupd\/article\/25\/1\/2\/5155324.","DOI":"10.1093\/humupd\/dmy033"},{"key":"2757_CR13","doi-asserted-by":"crossref","unstructured":"Boynukalin FK, Turgut NE, Gultomruk M, Ecemis S, Yarkiner Z, Findikli N, et al. Impact of elective frozen vs. fresh embryo transfer strategies on cumulative live birth: Do deleterious effects still exist in normal & hyper responders? PLoS One [Internet]. PLoS One; 2020 [cited 2022 Mar 17];15. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca\/32589634\/.","DOI":"10.1371\/journal.pone.0234481"},{"key":"2757_CR14","unstructured":"Chen Z-J, Shi Y, Sun Y, Zhang B, Liang X, Cao Y, et al. Fresh versus Frozen Embryos for Infertility in the Polycystic Ovary Syndrome. New England Journal of Medicine [Internet]. New England Journal of Medicine (NEJM\/MMS); 2016 [cited 2022 Apr 20];375:523\u201333. Available from: https:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa1513873."},{"key":"2757_CR15","doi-asserted-by":"crossref","unstructured":"Shi Y, Sun Y, Hao C, Zhang H, Wei D, Zhang Y, et al. Transfer of Fresh versus Frozen Embryos in Ovulatory Women. New England Journal of Medicine [Internet]. Massachusetts Medical Society; 2018 [cited 2022 Apr 20];378:126\u201336. Available from: https:\/\/www-nejm-org.proxy3.library.mcgill.ca\/doi\/10.1056\/NEJMoa1705334.","DOI":"10.1056\/NEJMoa1705334"},{"key":"2757_CR16","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.fertnstert.2013.12.026","volume":"101","author":"RG Steward","year":"2014","unstructured":"Steward RG, Lan L, Shah AA, Yeh JS, Price TM, Goldfarb JM, et al. Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles. Fertil Steril. 2014;101:967\u201373 (Elsevier).","journal-title":"Fertil Steril"},{"key":"2757_CR17","doi-asserted-by":"crossref","unstructured":"Pfeifer S, Butts S, Dumesic D, Fossum G, Giudice L, Gracia C, et al. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril [Internet]. Elsevier; 2015 [cited 2022 Mar 28];103:e9\u201317. Available from: http:\/\/www.fertstert.org\/article\/S0015028214025187\/fulltext.","DOI":"10.1016\/j.fertnstert.2014.12.093"},{"key":"2757_CR18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.maturitas.2006.11.007","volume":"56","author":"F Lorusso","year":"2007","unstructured":"Lorusso F, Vicino M, Lamanna G, Trerotoli P, Serio G, Depalo R. Performance of different ovarian reserve markers for predicting the numbers of oocytes retrieved and mature oocytes. Maturitas. 2007;56:429\u201335 (Elsevier).","journal-title":"Maturitas"},{"key":"2757_CR19","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1016\/j.fertnstert.2007.10.028","volume":"90","author":"K Jayaprakasan","year":"2008","unstructured":"Jayaprakasan K, Campbell B, Hopkisson J, Clewes J, Johnson I, Raine-Fenning N. Establishing the intercycle variability of three-dimensional ultrasonographic predictors of ovarian reserve. Fertil Steril. 2008;90:2126\u201332 (Elsevier).","journal-title":"Fertil Steril"},{"key":"2757_CR20","doi-asserted-by":"crossref","unstructured":"Broer SL, D\u00f3lleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJM. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update [Internet]. Oxford Academic; 2011 [cited 2022 Mar 17];17:46\u201354. Available from: https:\/\/academic.oup.com\/humupd\/article\/17\/1\/46\/639734.","DOI":"10.1093\/humupd\/dmq034"},{"key":"2757_CR21","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.fertnstert.2013.04.024","volume":"100","author":"SL Broer","year":"2013","unstructured":"Broer SL, D\u00f3lleman M, van Disseldorp J, Broeze KA, Opmeer BC, Bossuyt PMM, et al. Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis. Fertil Steril. 2013;100:420-429.e7 (Elsevier).","journal-title":"Fertil Steril"},{"key":"2757_CR22","doi-asserted-by":"crossref","unstructured":"Anckaert E, Smitz J, Schiettecatte J, Klein BM, Arce JC. The value of anti-M\u00fcllerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments. Hum Reprod [Internet]. Oxford University Press; 2012 [cited 2022 Mar 23];27:1829. Available from: \/pmc\/articles\/PMC3357198\/.","DOI":"10.1093\/humrep\/des101"},{"key":"2757_CR23","doi-asserted-by":"crossref","unstructured":"Arce JC, la Marca A, Mirner Klein B, Nyboe Andersen A, Fleming R. Antim\u00fcllerian hormone in gonadotropin releasing-hormone antagonist cycles: Prediction of ovarian response and cumulative treatment outcome in good-prognosis patients. Fertil Steril [Internet]. Elsevier Inc.; 2013 [cited 2022 Mar 23];99:1644\u201353. Available from: http:\/\/fertstertforum.com\/arcejc-antimullerian-hormone-gnrh-antagonist-ovarian-response\/.","DOI":"10.1016\/j.fertnstert.2012.12.048"},{"key":"2757_CR24","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.fertnstert.2014.12.114","volume":"103","author":"SM Nelson","year":"2015","unstructured":"Nelson SM, Klein BM, Arce JC. Comparison of antim\u00fcllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials. Fertil Steril. 2015;103:923-930.e1 (Elsevier).","journal-title":"Fertil Steril"},{"key":"2757_CR25","doi-asserted-by":"crossref","unstructured":"Peluso C, Oliveira R de, Laporta GZ, Christofolini DM, Fonseca FLA, Lagan\u00e0 AS, et al. Are ovarian reserve tests reliable in predicting ovarian response? Results from a prospective, cross-sectional, single-center analysis. Gynecol Endocrinol [Internet]. Gynecol Endocrinol; 2021 [cited 2022 Mar 23];37:358\u201366. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca\/32613875\/.","DOI":"10.1080\/09513590.2020.1786509"},{"key":"2757_CR26","doi-asserted-by":"crossref","unstructured":"Punchoo R, Bhoora S. Variation in the Measurement of Anti-M\u00fcllerian Hormone \u2013 What Are the Laboratory Issues? Front Endocrinol (Lausanne) [Internet]. Frontiers Media SA; 2021 [cited 2022 Mar 31];12. Available from: \/pmc\/articles\/PMC8446602\/.","DOI":"10.3389\/fendo.2021.719029"},{"key":"2757_CR27","doi-asserted-by":"crossref","unstructured":"Li HWR, Robertson DM, Burns C, Ledger WL. Challenges in Measuring AMH in the Clinical Setting. Front Endocrinol (Lausanne) [Internet]. Frontiers Media S.A.; 2021 [cited 2022 Mar 23];12. Available from: \/pmc\/articles\/PMC8183164\/.","DOI":"10.3389\/fendo.2021.691432"},{"key":"2757_CR28","doi-asserted-by":"crossref","unstructured":"Tarlatzi TB, Venetis CA, Devreker F, Englert Y, Delbaere A. What is the best predictor of severe ovarian hyperstimulation syndrome in IVF? A cohort study. J Assist Reprod Genet [Internet]. Springer; 2017 [cited 2022 Mar 28];34:1341. Available from: \/pmc\/articles\/PMC5633577\/.","DOI":"10.1007\/s10815-017-0990-7"},{"key":"2757_CR29","doi-asserted-by":"crossref","unstructured":"Delvigne A. Epidemiology of OHSS. Reprod Biomed Online [Internet]. 2009 [cited 2022 Mar 31];19:8\u201313. Available from: www.rbmonline.com\/Article\/3923.","DOI":"10.1016\/S1472-6483(10)60040-5"},{"key":"2757_CR30","doi-asserted-by":"crossref","unstructured":"Sousa M, Cunha M, Teixeira da Silva J, Oliveira C, Silva J, Viana P, et al. Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles. Reprod Biol Endocrinol [Internet]. Reprod Biol Endocrinol; 2015 [cited 2022 Mar 31];13. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca\/26100393\/.","DOI":"10.1186\/s12958-015-0067-3"},{"key":"2757_CR31","doi-asserted-by":"crossref","unstructured":"Shibahara H, Shimada K, Morimatsu Y, Kikuchi K, Hirano Y, Suzuki T, et al. Severe ovarian hyperstimulation syndrome in a 42\u2010year\u2010old woman with successful pregnancy after intracytoplasmic sperm injection embryo transfer. Reprod Med Biol [Internet]. Wiley-Blackwell; 2005 [cited 2022 Mar 31];4:265. Available from: \/pmc\/articles\/PMC5904648\/.","DOI":"10.1111\/j.1447-0578.2005.00112.x"},{"key":"2757_CR32","doi-asserted-by":"crossref","unstructured":"van der Weiden RMF, Meijers CJH, Hegt VN. Ectopic mesothelial cell proliferation in cervical lymph nodes after severe ovarian hyperstimulation syndrome. Fertil Steril [Internet]. Fertil Steril; 2005 [cited 2022 Mar 31];83:739\u201341. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15749507\/.","DOI":"10.1016\/j.fertnstert.2004.11.011"},{"key":"2757_CR33","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.fertnstert.2009.05.092","volume":"94","author":"B Luke","year":"2010","unstructured":"Luke B, Brown MB, Morbeck DE, Hudson SB, Coddington CC, Stern JE. Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome. Fertil Steril. 2010;94:1399\u2013404 (Elsevier).","journal-title":"Fertil Steril"},{"key":"2757_CR34","doi-asserted-by":"crossref","unstructured":"la Marca A, Giulini S, Tirelli A, Bertucci E, Marsella T, Xella S, et al. Anti-M\u00fcllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Human Reproduction [Internet]. Oxford Academic; 2007 [cited 2022 Mar 31];22:766\u201371. Available from: https:\/\/academic.oup.com\/humrep\/article\/22\/3\/766\/2939092.","DOI":"10.1093\/humrep\/del421"},{"key":"2757_CR35","doi-asserted-by":"crossref","unstructured":"Ferraretti AP, la Marca A, Fauser BCJM, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of \u2018poor response\u2019\u2019 to ovarian stimulation for in vitro fertilization: the Bologna criteria\u2019. Human Reproduction [Internet]. Oxford Academic; 2011 [cited 2022 Mar 31];26:1616\u201324. Available from: https:\/\/academic.oup.com\/humrep\/article\/26\/7\/1616\/2913872.","DOI":"10.1093\/humrep\/der092"},{"key":"2757_CR36","doi-asserted-by":"crossref","unstructured":"Alviggi C, Andersen CY, Buehler K, Conforti A, de Placido G, Esteves SC, et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril [Internet]. Elsevier; 2016 [cited 2022 Mar 31];105:1452\u20133. Available from: http:\/\/www.fertstert.org\/article\/S0015028216000893\/fulltext.","DOI":"10.1016\/j.fertnstert.2016.02.005"},{"key":"2757_CR37","doi-asserted-by":"crossref","unstructured":"Nakhuda GS, Chu MC, Wang JG, Sauer M v., Lobo RA. Elevated serum m\u00fcllerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normal women undergoing in vitro fertilization. Fertil Steril [Internet]. Elsevier; 2006 [cited 2022 Mar 31];85:1541\u20133. Available from: http:\/\/www.fertstert.org\/article\/S0015028206000963\/fulltext.","DOI":"10.1016\/j.fertnstert.2005.10.052"},{"key":"2757_CR38","doi-asserted-by":"crossref","unstructured":"Lee TH, Liu CH, Huang CC, Wu YL, Shih YT, Ho HN, et al. Serum anti-m\u00fcllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Human Reproduction [Internet]. Oxford Academic; 2008 [cited 2022 Mar 31];23:160\u20137. Available from: https:\/\/academic.oup.com\/humrep\/article\/23\/1\/160\/561979.","DOI":"10.1093\/humrep\/dem254"},{"key":"2757_CR39","doi-asserted-by":"crossref","unstructured":"Ocal P, Sahmay S, Cetin M, Irez T, Guralp O, Cepni I. Serum anti-M\u00fcllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles. J Assist Reprod Genet [Internet]. J Assist Reprod Genet; 2011 [cited 2022 Mar 31];28:1197\u2013203. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca\/21882017\/.","DOI":"10.1007\/s10815-011-9627-4"},{"key":"2757_CR40","unstructured":"Salmassi A, Mettler L, Hedderich J, Jonat W, Deenadaya A, von Otte S, et al. Cut-Off Levels of Anti-Mullerian Hormone for The Prediction of Ovarian Response, In Vitro Fertilization Outcome and Ovarian Hyperstimulation Syndrome. Int J Fertil Steril [Internet]. Royan Institute; 2015 [cited 2022 Mar 31];9:157. Available from: \/pmc\/articles\/PMC4518483\/."},{"key":"2757_CR41","doi-asserted-by":"crossref","unstructured":"Vembu R, Reddy NS. Serum AMH Level to Predict the Hyper Response in Women with PCOS and Non-PCOS Undergoing Controlled Ovarian Stimulation in ART. J Hum Reprod Sci [Internet]. J Hum Reprod Sci; 2017 [cited 2022 Mar 31];10:91\u20134. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca\/28904496\/.","DOI":"10.4103\/jhrs.JHRS_15_16"},{"key":"2757_CR42","unstructured":"Sene AA, Ashrafi M, Alaghmand-Fard N, Mohammadi N, Alisaraie MM, Alizadeh A. Anti-M\u00fcllerian Hormone Predictive Levels to Determine The Likelihood of Ovarian Hyper-Response in Infertile Women with Polycystic Ovarian Morphology. Int J Fertil Steril [Internet]. Int J Fertil Steril; 2021 [cited 2022 Mar 31];15:115\u201322. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca\/33687164\/."},{"key":"2757_CR43","doi-asserted-by":"crossref","unstructured":"Aflatoonian A, Oskouian H, Ahmadi S, Oskouian L. Prediction of high ovarian response to controlled ovarian hyperstimulation: anti-M\u00fcllerian hormone versus small antral follicle count (2\u20136 mm). J Assist Reprod Genet [Internet]. J Assist Reprod Genet; 2009 [cited 2022 Mar 24];26:319\u201325. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19543966\/.","DOI":"10.1007\/s10815-009-9319-5"},{"key":"2757_CR44","unstructured":"Fertility problems: assessment and treatment Clinical guideline. 2013 [cited 2022 Apr 1]; Available from: www.nice.org.uk\/guidance\/cg156."},{"key":"2757_CR45","doi-asserted-by":"crossref","unstructured":"Izhar R, Husain S, Tahir MA, Kausar M, Sana T, Ghalib F. Antral follicle count and anti-M\u00fcllerian hormone level as predictors of ovarian hyperstimulation syndrome in women with polycystic ovarian syndrome undergoing controlled ovarian stimulation. J Ultrason [Internet]. Polish Ultrasound Society; 2021 [cited 2022 Apr 1];21:e200. Available from: \/pmc\/articles\/PMC8439128\/.","DOI":"10.15557\/JoU.2021.0032"},{"key":"2757_CR46","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.fertnstert.2005.07.1292","volume":"85","author":"EG Papanikolaou","year":"2006","unstructured":"Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, et al. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril. 2006;85:112\u201320 (Elsevier).","journal-title":"Fertil Steril"},{"key":"2757_CR47","doi-asserted-by":"crossref","unstructured":"Griesinger G, Verweij PJM, Gates D, Devroey P, Gordon K, Stegmann BJ, et al. Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol. PLoS One [Internet]. Public Library of Science; 2016 [cited 2022 Apr 4];11:e0149615. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0149615.","DOI":"10.1371\/journal.pone.0149615"},{"key":"2757_CR48","doi-asserted-by":"crossref","unstructured":"Sim\u00f3n C, Cano F, Valbuena D, Remoh\u00ed J, Pellicer A. Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. Hum Reprod [Internet]. Hum Reprod; 1995 [cited 2022 Apr 4];10:2432\u20137. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca\/8530680\/.","DOI":"10.1093\/oxfordjournals.humrep.a136313"},{"key":"2757_CR49","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0015-0282(98)00140-X","volume":"70","author":"C Sim\u00f3n","year":"1998","unstructured":"Sim\u00f3n C, Garcia Velasco JJ, Valbuena D, Peinado JA, Moreno C, Remoh\u00ed J, et al. Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen. Fertil Steril. 1998;70:234\u20139 (Elsevier).","journal-title":"Fertil Steril"},{"key":"2757_CR50","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/S0015-0282(16)58337-X","volume":"65","author":"A Pellicer","year":"1996","unstructured":"Pellicer A, Valbuena D, Cano F, Remohi J, Simon C. Lower implantation rates in high responders: evidence for an altered endocrine milieu during the preimplantation period. Fertil Steril. 1996;65:1190\u20135 (Elsevier).","journal-title":"Fertil Steril"},{"key":"2757_CR51","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0015-0282(99)00293-9","volume":"72","author":"FI Sharara","year":"1999","unstructured":"Sharara FI, McClamrock HD. High estradiol levels and high oocyte yield are not detrimental to in vitro fertilization outcome. Fertil Steril. 1999;72:401\u20135 (Elsevier).","journal-title":"Fertil Steril"},{"key":"2757_CR52","doi-asserted-by":"crossref","unstructured":"Er\u015fahin AA, Acet M, Er\u015fahin SS, Dokuzeyl\u00fcl G\u00fcng\u00f6r N. Frozen embryo transfer prevents the detrimental effect of high estrogen on endometrium receptivity. J Turk Ger Gynecol Assoc [Internet]. J Turk Ger Gynecol Assoc; 2017 [cited 2022 Apr 4];18:38\u201342. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca\/28506949\/.","DOI":"10.4274\/jtgga.2016.0186"},{"key":"2757_CR53","doi-asserted-by":"crossref","unstructured":"Ng EHY, Yeung WSB, Lau EYL, So WWK, Ho PC. High serum oestradiol concentrations in fresh IVF cycles do not impair implantation and pregnancy rates in subsequent frozen\u2013thawed embryo transfer cycles. Human Reproduction [Internet]. Oxford Academic; 2000 [cited 2022 Apr 4];15:250\u20135. Available from: https:\/\/academic.oup.com\/humrep\/article\/15\/2\/250\/555181.","DOI":"10.1093\/humrep\/15.2.250"},{"key":"2757_CR54","doi-asserted-by":"crossref","unstructured":"Li HWR, Lee VCY, Lau EYL, Yeung WSB, Ho PC, Ng EHY. Cumulative live-birth rate in women with polycystic ovary syndrome or isolated polycystic ovaries undergoing in-vitro fertilisation treatment. J Assist Reprod Genet [Internet]. Springer; 2014 [cited 2022 Mar 28];31:205. Available from: \/pmc\/articles\/PMC3933606\/.","DOI":"10.1007\/s10815-013-0151-6"},{"key":"2757_CR55","doi-asserted-by":"crossref","unstructured":"Doronzo G, Russo I, Mattiello L, Anfossi G, Bosia A, Trovati M. Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance. Eur J Clin Invest [Internet]. John Wiley & Sons, Ltd; 2004 [cited 2022 Apr 20];34:664\u201373. Available from: https:\/\/onlinelibrary-wiley-com.proxy3.library.mcgill.ca\/doi\/full\/10.1111\/j.1365-2362.2004.01412.x.","DOI":"10.1111\/j.1365-2362.2004.01412.x"},{"key":"2757_CR56","doi-asserted-by":"crossref","unstructured":"G\u00f3mez R, Ferrero H, Delgado-Rosas F, Gaytan M, Morales C, Zimmermann RC, et al. Evidences for the existence of a low dopaminergic tone in polycystic ovarian syndrome: implications for OHSS development and treatment. J Clin Endocrinol Metab [Internet]. J Clin Endocrinol Metab; 2011 [cited 2022 Apr 20];96:2484\u201392. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca\/21646367\/.","DOI":"10.1210\/jc.2011-0075"},{"key":"2757_CR57","doi-asserted-by":"crossref","unstructured":"Carvalho LML, dos Reis FM, Candido AL, Nunes FFC, Ferreira CN, Gomes KB. Polycystic Ovary Syndrome as a systemic disease with multiple molecular pathways: a narrative review. Endocr Regul [Internet]. Endocr Regul; 2018 [cited 2022 Apr 30];52:208\u201321. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.proxy3.library.mcgill.ca\/31517612\/.","DOI":"10.2478\/enr-2018-0026"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-023-02757-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-023-02757-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-023-02757-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T05:08:53Z","timestamp":1685768933000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-023-02757-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,18]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["2757"],"URL":"https:\/\/doi.org\/10.1007\/s10815-023-02757-4","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,18]]},"assertion":[{"value":"5 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All declarations of interest are outside the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u2022 Peter Humaidan reports reception of lecture honoraria from Merck, Gedoeon Richter and IBSA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u2022 Antonio La Marca reports reception of consulting fees from Merck, Organon, Ferring, Gedeon Richter, Theramex, Beckman Coulter, and Roche.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u2022 Samuel Santos-Ribeiro reports reception of research funding from Roche diagnostics, Organon and Theramex; reception of consulting fees from Organon, MSD and Ferring; honoraria for lectures from Ferring, Besins, MSD\/Organon, Theramex and Gedeon Richter; reception of equipment materials or other services from Roche diagnostics and Ferring and is deputy of the SQART SIG in ESHRE.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u2022 Alessandro Conforti reports reception of grants from the University of Naples Federico II; recpetion honoraria from Medea, Event Planet and Merck.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u2022 Baris Ata \u2013 reports reception of consulting fees from Merck GmBH \u2013 Turkey, reception of payment or honoraria from Abbott, Merck GmBH and Ferring; reception of support for attending meetings or travel from IBSA; is president of the Turkish Society of Reproductive Medicine and is an executive committee member of ESHRE.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u2022 Juan Garcia Velasco \u2013 reports reception of payment or honoraria for lectures or educational events from Merck, Ferring, MSD, Organon, Theramex and Gedeon Richter.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u2022 George Lainas\u2014reports reception of payment or honoraria for lectures or educational events from Merck and Ferring, payment for expert testimony from Merck and support for attending meetings from ESHRE. He also participated in data safety monitoring or advisory board of Merck.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u2022 Filippo Maria Ubaldi is the scientific director of GeneraLife and minority shareholder of the company. He is also president of SIFES-MR (the Italian Society of Fertility, Sterility and Reproductive Medicine), and member of the scientific board of Medea. In the last three years, F.M. Ubaldi has received honoraria or consultation fees from Merck, MSD, Ferring, Gedeon Richter, Organon and Ibsa.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u2022 Sesh Sunkara reports reception of payment or honoraria for lectured from, Merck Ferring and MSD.","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u2022 Raoul Orvieto reports reception of consulting fees from Merck and Ferring and payment or honoraria for lectures from Merck and Ferring.","order":11,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u2022 Nikolaos Polyzos reports reception of grants or contracts from Merck Serono, IBSA, Organon, Ferring, Roche, Theramex, Besins Healthcare and Gedeon Richter and reception of consulting fees from Merck Serono, IBSA, Organon, Ferring, Besins Healthcare and Gedeon Richter.","order":12,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u2022 Ben Mol reports reception of an investigator grant from NHMRC, he reports consultancy at an hourly rate for ObsEva, Merck Merck KGaA and Guerbet and reception of travel support from Merck Merck KGaA.","order":13,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u2022 Hakan Yarali reports unrestricted grants from Merck, honoraria for lectures from Merck and IBSA, support for attending meetings from Merck, IBSA and Ferring.","order":14,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u2022 Human Fatemi reports receiving research grants from Merck Serono and Organon, consulting fees from Ferring global, speaker honoraria from Organon, Merck Serono and Ferring and participation in data safety monitoring or advisory board for Ferring.","order":15,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u2022 Sandro Esteves reports unrestricted research grants from Merck KGaA, reception of consulting fees from Merck, MeD.E.A and event planet, reception of honoraria for lectures from Merck, MeD.E.A and event planet, has a patent on the ART calculator, is an unpaid advisory board member for Nature Reviews and for Urology, Is the Head, Department of Education and Research, Brazilian Society of Urology (S\u00e3o Paulo section; unpaid) and is the Co-chair, Male Infertility Special Interest Group, WHO Infertility Guidelines (unpaid).","order":16,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u2022 Ariel Weissman reports no conflicts of interest.\u2022 Christophe Blockeel reports no conflicts of interest.\u2022 Seang Lin Tan reports no conflicts of interest.\u2022 Michael Dahan reports no conflicts of interest.\u2022 Bulent Urman reports no conflicts of interest.\u2022 RJ Norman reports no conflict of interest.\u2022 Richard Paulson reports no conflicts of interest.\u2022 Ido Feferkorn reports no conflicts of interest.","order":17,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}